SPARC-deficient urothelial lesions exhibited a significant progressive increase in proliferation compared to SPARC-proficient lesions with significantly increasing higher levels of cyclins A1, D1 and E2 that drive cell cycle progression and were positively correlated with the presence, invasion, progression and metastasis of human bladder cancer [53, 54]. The gene discussed is SPARC; the disease is urinary bladder cancer.